Annals of Neurology · 1997 · 325 citations · 12 references
Life SciencesBiochemistryNeuroscienceMitochondrial BiologyNeurochemistryNeurodegenerationMitochondrial BiochemistryMitochondrial DysfunctionMitochondrial PhysiologyNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseCoenzyme Q MetabolismCoenzyme Q10 DeficiencyMitochondrial Respiratory ComplexesRespiratory Chain Dysfunction
The activities of complex I and complex II/III in platelet mitochondria are reduced in patients with early, untreated Parkinson's disease. Coenzyme Q10 is the electron acceptor for complex I and complex II. We found that the level of coenzyme Q10 was significantly lower in mitochondria from parkinsonian patients than in mitochondria from age- and sex-matched control subjects and that the levels of coenzyme Q10 and the activities of complex I and complex II/III were significantly correlated.
12
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
J. William Langston, Philip L. Ballard, James W. Tetrud et al. · Science · 1983 · 4.9K citations
Oxygen radicals and the nervous system
Barry Halliwell, John M.C. Gutteridge · Trends in Neurosciences · 1985 · 820 citations